Distler JHW - Search Results

1

Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis.

Liang M, Dickel N, Györfi AH, SafakTümerdem B, Li YN, Rigau AR, Liang C, Hong X, Shen L, Matei AE, Trinh-Minh T, Tran-Manh C, Zhou X, Zehender A, Kreuter A, Zou H, Schett G, Kunz M, Distler JHW. Liang M, et al. Among authors: distler jhw. Sci Transl Med. 2024 Mar 27;16(740):eadd6570. doi: 10.1126/scitranslmed.add6570. Epub 2024 Mar 27. Sci Transl Med. 2024. PMID: 38536934

2

Angiogenesis and vasculogenesis in systemic sclerosis.

Distler JH, Gay S, Distler O. Distler JH, et al. Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii26-7. doi: 10.1093/rheumatology/kel295. Rheumatology (Oxford). 2006. PMID: 16987827 Review.

3

Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.

Distler JH, Jüngel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O. Distler JH, et al. Arthritis Rheum. 2007 Jan;56(1):311-22. doi: 10.1002/art.22314. Arthritis Rheum. 2007. PMID: 17195235 Free article.

4

Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.

Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O. Distler JH, et al. Arthritis Rheum. 2007 Dec;56(12):4203-15. doi: 10.1002/art.23074. Arthritis Rheum. 2007. PMID: 18050252 Free article.

5

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis.

Akhmetshina A, Dees C, Pileckyte M, Maurer B, Axmann R, Jüngel A, Zwerina J, Gay S, Schett G, Distler O, Distler JH. Akhmetshina A, et al. FASEB J. 2008 Jul;22(7):2214-22. doi: 10.1096/fj.07-105627. Epub 2008 Mar 7. FASEB J. 2008. PMID: 18326784

6

Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis.

Skhirtladze C, Distler O, Dees C, Akhmetshina A, Busch N, Venalis P, Zwerina J, Spriewald B, Pileckyte M, Schett G, Distler JH. Skhirtladze C, et al. Arthritis Rheum. 2008 May;58(5):1475-84. doi: 10.1002/art.23436. Arthritis Rheum. 2008. PMID: 18438865 Free article.

7

Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease.

Distler JH, Manger B, Spriewald BM, Schett G, Distler O. Distler JH, et al. Arthritis Rheum. 2008 Aug;58(8):2538-42. doi: 10.1002/art.23694. Arthritis Rheum. 2008. PMID: 18668536 Free article.

8

Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.

Akhmetshina A, Dees C, Pileckyte M, Szucs G, Spriewald BM, Zwerina J, Distler O, Schett G, Distler JH. Akhmetshina A, et al. Arthritis Rheum. 2008 Aug;58(8):2553-64. doi: 10.1002/art.23677. Arthritis Rheum. 2008. PMID: 18668558 Free article.

9

The controversial role of tumor necrosis factor alpha in fibrotic diseases.

Distler JH, Schett G, Gay S, Distler O. Distler JH, et al. Arthritis Rheum. 2008 Aug;58(8):2228-35. doi: 10.1002/art.23645. Arthritis Rheum. 2008. PMID: 18668576 Free article. Review. No abstract available.

10

Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo.

Venalis P, Maurer B, Akhmetshina A, Busch N, Dees C, Stürzl M, Zwerina J, Jüngel A, Gay S, Schett G, Distler O, Distler JH. Venalis P, et al. J Cell Mol Med. 2009 Oct;13(10):4185-91. doi: 10.1111/j.1582-4934.2008.00492.x. J Cell Mol Med. 2009. PMID: 18774958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page